Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 12/20 | 0.52 |
| ▸ | CRBN | Q96SW2 | 12/20 | 0.52 |
| ▸ | CETP | P11597 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29323374 | 0.87 | DDB1 (0.47) | DDB1CRBNCETPEPHX2NOD2 | |
| SCHEMBL29323894 | 0.87 | DDB1 (0.48) | DDB1CRBNEPHX2ALDH1A1KDM4E | |
| SCHEMBL29323657 | 0.86 | CRBN (0.40) | DDB1CRBNALDH1A1NPC1KDM4E | |
| SCHEMBL23640001 | 0.86 | DDB1 (0.49) | DDB1CRBNEPHX2 | |
| SCHEMBL29322766 | 0.81 | DDB1 (0.48) | DDB1CRBNCETPEPHX2ALDH1A1 | |
| SCHEMBL29322819 | 0.81 | DDB1 (0.50) | DDB1CRBNCETPEPHX2ALDH1A1 | |
| SCHEMBL24302306 | 0.81 | DDB1 (0.51) | DDB1CRBN | |
| SCHEMBL24302304 | 0.81 | DDB1 (0.51) | DDB1CRBN | |
| SCHEMBL24303089 | 0.81 | DDB1 (0.51) | DDB1CRBN | |
| SCHEMBL23640202 | 0.79 | CRBN (0.44) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400499-A1 | GLUTARIMIDE COMPOUND AND USE THEREOF | Medshine Discovery Inc. (CN) | 2024-07-17 | — | — | EP | disclosed |